- Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients Bristol Myers Squibb
- Bristol Myers, Bain Capital form new company to develop immunology drugs Reuters
- Bristol Myers, Bain Capital form a new biopharmaceutical company Seeking Alpha
- Bristol Myers Squibb and Bain Capital Form New Immunology Company The Wall Street Journal
- Bain Capital and Bristol Myers Squibb form new biopharma company pehub.com
Source link
